Evidence map›Paper›PMID 27973597›Full record

ArticlePloS one2016

Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan.

Yue Chen, Bhavna Hora, Todd DeMarco, Sharaf Ali Shah, Manzoor Ahmed, Ana M Sanchez, Chang Su, Meredith Carter, Mars Stone, Rumina Hasan and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Yue ChenDuke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Bhavna HoraDuke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Todd DeMarcoDuke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Sharaf Ali ShahBridge Consultants Foundation, Karachi, Pakistan.
Manzoor AhmedBridge Consultants Foundation, Karachi, Pakistan.
Ana M SanchezDuke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Chang SuDuke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Meredith CarterDuke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Mars StoneBlood Systems Research Institute, San Francisco, California, United States of America.
Rumina HasanDepartment of Pathology, Aga Khan University, Karachi, Pakistan.
Zahra HasanDepartment of Pathology, Aga Khan University, Karachi, Pakistan.
Michael P BuschBlood Systems Research Institute, San Francisco, California, United States of America.
Thomas N DennyDuke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Feng GaoDuke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Duke Medical Center · USAga Khan University · PKBlood Systems Research Institute · USBridge Consultants Foundation · PK

Funding

NIAID NIH HHS HHSN272200800014CNIAID NIH HHS HHSN272201000045C
6 · The paper itself

Abstract

A number of HIV-1 subtypes are identified in Pakistan by characterization of partial viral gene sequences. Little is known whether new recombinants are generated and how they disseminate since whole genome sequences for these viruses have not been characterized. Near full-length genome (NFLG) sequences were obtained by amplifying two overlapping half genomes or next generation sequencing from 34 HIV-1-infected individuals in Pakistan. Phylogenetic tree analysis showed that the newly characterized sequences were 16 subtype As, one subtype C, and 17 A/G recombinants. Further analysis showed that all 16 subtype A1 sequences (47%), together with the vast majority of sequences from Pakistan from other studies, formed a tight subcluster (A1a) within the subtype A1 clade, suggesting that they were derived from a single introduction. More in-depth analysis of 17 A/G NFLG sequences showed that five shared similar recombination breakpoints as in CRF02 (15%) but were phylogenetically distinct from the prototype CRF02 by forming a tight subcluster (CRF02a) while 12 (38%) were new recombinants between CRF02a and A1a or a divergent A1b viruses. Unique recombination patterns among the majority of the newly characterized recombinants indicated ongoing recombination. Interestingly, recombination breakpoints in these CRF02/A1 recombinants were similar to those in prototype CRF02 viruses, indicating that recombination at these sites more likely generate variable recombinant viruses. The dominance and fast dissemination of new CRF02a/A1 recombinants over prototype CRF02 suggest that these recombinant have more adapted and may become major epidemic strains in Pakistan.

Indexed as

Recombination, GeneticAdolescentAdultEvolution, MolecularFemaleGenome, ViralHigh-Throughput Nucleotide SequencingHIV-1HIV InfectionsHumansMaleMiddle AgedModels, StatisticalPakistanPhylogenyRegression Analysis

Identifiers

PMID27973597
PMCPMC5156399
OpenAlexW2562804276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.